3,890 Shares in Dolby Laboratories $DLB Acquired by United Services Automobile Association

Key Points

• United Services Automobile Association acquired 3,890 shares of Dolby Laboratories valued at approximately $311,000 in the first quarter, indicating growing institutional interest in the company.
• Dolby Laboratories reported $0.78 EPS in its latest earnings, beating expectations, and its revenue increased by 9.2% compared to the prior year.
• The company recently announced a quarterly dividend of $0.33 per share, representing an annualized yield of 1.8%, with a payout ratio of 48.35%.

United Services Automobile Association acquired a new position in Dolby Laboratories (NYSE:DLB - Free Report) in the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund acquired 3,890 shares of the electronics maker's stock, valued at approximately $311,000.

A number of other hedge funds also recently added to or reduced their stakes in DLB. Palogic Value Management L.P. grew its position in Dolby Laboratories by 6.4% in the 4th quarter. Palogic Value Management L.P. now owns 3,888 shares of the electronics maker's stock worth $304,000 after purchasing an additional 235 shares during the period. BNP Paribas Financial Markets grew its position in Dolby Laboratories by 123.1% in the 4th quarter. BNP Paribas Financial Markets now owns 30,041 shares of the electronics maker's stock worth $2,346,000 after purchasing an additional 16,578 shares during the period. Cetera Investment Advisers grew its position in Dolby Laboratories by 16.4% in the 4th quarter. Cetera Investment Advisers now owns 4,601 shares of the electronics maker's stock worth $359,000 after purchasing an additional 648 shares during the period. Gotham Asset Management LLC grew its position in Dolby Laboratories by 37.6% in the 4th quarter. Gotham Asset Management LLC now owns 11,594 shares of the electronics maker's stock worth $905,000 after purchasing an additional 3,167 shares during the period. Finally, Laird Norton Wetherby Wealth Management LLC grew its position in Dolby Laboratories by 8.9% in the 4th quarter. Laird Norton Wetherby Wealth Management LLC now owns 4,220 shares of the electronics maker's stock worth $330,000 after purchasing an additional 346 shares during the period. 58.56% of the stock is currently owned by hedge funds and other institutional investors.

Dolby Laboratories Stock Down 0.9%

Shares of DLB stock opened at $71.48 on Friday. The company's fifty day simple moving average is $73.73 and its two-hundred day simple moving average is $75.53. The stock has a market cap of $6.85 billion, a P/E ratio of 26.18 and a beta of 0.93. Dolby Laboratories has a 52 week low of $68.24 and a 52 week high of $89.66.

Dolby Laboratories (NYSE:DLB - Get Free Report) last announced its earnings results on Thursday, July 31st. The electronics maker reported $0.78 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.72 by $0.06. The firm had revenue of $315.55 million for the quarter, compared to analysts' expectations of $305.23 million. Dolby Laboratories had a net margin of 19.62% and a return on equity of 11.52%. The business's revenue was up 9.2% compared to the same quarter last year. During the same period in the prior year, the company earned $0.71 EPS. Dolby Laboratories has set its FY 2025 guidance at 3.880-4.030 EPS. Q4 2025 guidance at 0.610-0.760 EPS. On average, analysts anticipate that Dolby Laboratories will post 2.94 EPS for the current fiscal year.

Dolby Laboratories Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Wednesday, August 20th. Stockholders of record on Tuesday, August 12th were given a dividend of $0.33 per share. This represents a $1.32 annualized dividend and a dividend yield of 1.8%. The ex-dividend date was Tuesday, August 12th. Dolby Laboratories's dividend payout ratio is currently 48.35%.

Insider Activity

In related news, CEO Kevin J. Yeaman sold 25,000 shares of the stock in a transaction dated Tuesday, August 12th. The shares were sold at an average price of $72.31, for a total value of $1,807,750.00. Following the sale, the chief executive officer directly owned 114,725 shares of the company's stock, valued at $8,295,764.75. This represents a 17.89% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, SVP Shriram Revankar sold 7,000 shares of the stock in a transaction dated Friday, August 22nd. The stock was sold at an average price of $74.92, for a total transaction of $524,440.00. Following the completion of the sale, the senior vice president directly owned 70,435 shares in the company, valued at $5,276,990.20. This trade represents a 9.04% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 99,366 shares of company stock worth $7,352,963 over the last 90 days. Corporate insiders own 38.39% of the company's stock.

Wall Street Analyst Weigh In

A number of equities research analysts have commented on DLB shares. Tigress Financial lifted their target price on shares of Dolby Laboratories from $112.00 to $114.00 and gave the stock a "buy" rating in a research report on Friday, August 15th. Barrington Research reaffirmed an "outperform" rating and issued a $100.00 target price on shares of Dolby Laboratories in a research report on Friday. Wall Street Zen raised shares of Dolby Laboratories from a "hold" rating to a "buy" rating in a research report on Saturday, August 30th. Robert W. Baird began coverage on shares of Dolby Laboratories in a report on Friday, September 5th. They issued a "neutral" rating and a $74.00 target price for the company. Finally, Baird R W raised shares of Dolby Laboratories to a "hold" rating in a report on Friday, September 5th. Three equities research analysts have rated the stock with a Buy rating and two have given a Hold rating to the company. According to MarketBeat.com, Dolby Laboratories has an average rating of "Moderate Buy" and a consensus target price of $95.75.

About Dolby Laboratories

Dolby Laboratories, Inc creates audio and imaging technologies that transform entertainment at the cinema, DTV transmissions and devices, mobile devices, OTT video and music services, home entertainment devices, and automobiles. The company develops and licenses its audio technologies, such as AAC & HE-AAC, a digital audio codec solution used for a range of media applications; AVC, a digital video codec with high bandwidth efficiency used in various media devices; Dolby AC-4, a digital audio coding technology that delivers new audio experiences to a range of playback devices; and Dolby Atmos technology for cinema and various media devices.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.